BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Furusyo N, Katoh M, Tanabe Y, Kajiwara E, Maruyama T, Shimono J, Sakai H, Nakamuta M, Nomura H, Masumoto A, Shimoda S, Takahashi K, Azuma K, Hayashi J, Group KULDS. Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: A project of the Kyushu University Liver Disease Study Group. World J Gastroenterol 2006; 12(5): 784-790 [PMID: 16521196 DOI: 10.3748/wjg.v12.i5.784]
URL: https://www.wjgnet.com/1007-9327/full/v12/i5/784.htm
Number Citing Articles
1
Norihiro Furusyo, Masayuki Murata, Jun Hayashi. Hepatitis C Virus Disease2008; : 148 doi: 10.1007/978-0-387-71376-2_8
2
M. RAHMANI, M. N. TOOSI, K. GHANNADI, G. R. LARI, M. JAZEBI, M. RASOULZADEGAN, F. ALA. Clinical outcome of interferon and ribavirin combination treatment in hepatitis C virus infected patients with congenital bleeding disorders in IranHaemophilia 2009; 15(5): 1097 doi: 10.1111/j.1365-2516.2009.02042.x
3
Mosaburo Kainuma, Norihiro Furusyo, Koichi Azuma, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Yuichi Tanabe, Takeaki Satoh, Toshihiro Maruyama, Makoto Nakamuta, Kazuhiro Kotoh, Shinji Shimoda, Jun Hayashi. Pegylated interferon α‐2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferaseHepatology Research 2012; 42(1): 33 doi: 10.1111/j.1872-034X.2011.00907.x
4
Eiichi Ogawa, Norihiro Furusyo, Kazuhiro Toyoda, Hiroaki Takeoka, Shigeru Otaguro, Maki Hamada, Masayuki Murata, Yasunori Sawayama, Jun Hayashi. Transient elastography for patients with chronic hepatitis B and C virus infection: Non‐invasive, quantitative assessment of liver fibrosisHepatology Research 2007; 37(12): 1002 doi: 10.1111/j.1872-034X.2007.00160.x
5
Shinji Shimoda, Kosuke Sumida, Sho Iwasaka, Satomi Hisamoto, Hironori Tanimoto, Hideyuki Nomura, Kazufumi Dohmen, Kazuhiro Takahashi, Akira Kawano, Eiichi Ogawa, Norihiro Furusyo, Koichi Akashi, Jun Hayashi. Interferon-α-Induced Changes to Natural Killer Cells Are Associated with the Treatment Outcomes in Patients with HCV InfectionsHepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/374196
6
Nader Nemr, Rania Kishk, Mohamed Mandour. Role of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis CIndian Journal of Gastroenterology 2016; 35(1): 7 doi: 10.1007/s12664-016-0618-3
7
Norihiro Furusyo, Yasunori Sawayama, Shinji Maeda, Kazuhiro Toyoda, Hiroaki Takeoka, Masayuki Murata, Hachiro Ohnishi, Jun Hayashi. High molecular weight form of adiponectin levels of Japanese patients with chronic hepatitis C virus infectionHepatology Research 2007; 37(12): 1052 doi: 10.1111/j.1872-034X.2007.00159.x
8
Maissa El Raziky, Naglaa A. Zayed, Amin Abdel Baki, Shimaa A. Mansour, Rasha M. H. Shahin. ITPA gene polymorphism (94C>A) effects on ribavirin‐induced anemia during therapy in Egyptian patients with chronic hepatitis CJournal of Medical Virology 2017; 89(10): 1823 doi: 10.1002/jmv.24844
9
Eiichi Ogawa, Norihiro Furusyo, Kazuhiro Toyoda, Hiroaki Taniai, Shigeru Otaguro, Mosaburo Kainuma, Masayuki Murata, Yasunori Sawayama, Jun Hayashi. Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatmentBMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-38
10
Norihiro Furusyo, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Yuichi Tanabe, Akihide Masumoto, Toshihiro Maruyama, Makoto Nakamuta, Munechika Enjoji, Koichi Azuma, Junya Shimono, Hironori Sakai, Shinji Shimoda, Jun Hayashi. Association between the treatment length and cumulative dose of pegylated interferon alpha‐2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study GroupJournal of Gastroenterology and Hepatology 2008; 23(7pt1): 1094 doi: 10.1111/j.1440-1746.2008.05319.x
11
Kyoko Okada, Norihiro Furusyo, Eiichi Ogawa, Hiroaki Ikezaki, Tsuyoshi Ihara, Takeo Hayashi, Mosaburo Kainuma, Masayuki Murata, Jun Hayashi. Association between chronic hepatitis C virus infection and high levels of circulating N-terminal pro-brain natriuretic peptideEndocrine 2013; 43(1): 200 doi: 10.1007/s12020-012-9688-x
12
Hiroaki Ikezaki, Norihiro Furusyo, Takeshi Ihara, Takeo Hayashi, Eiichi Ogawa, Kazuhiro Toyoda, Hiroaki Taniai, Mosaburo Kainuma, Masayuki Murata, Jun Hayashi. Abbott RealTime PCR assay is useful for evaluating virological response to antiviral treatment for chronic hepatitis CJournal of Infection and Chemotherapy 2011; 17(6): 737 doi: 10.1007/s10156-011-0249-7
13
Mohammad Pouryasin, Maryam Keshvari, Heidar Sharafi, Seyed Moayed Alavian, Bita Behnava, Seyed Ehsan Alavian, Ali Pouryasin. The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis CHepatitis Monthly 2016; 16(2) doi: 10.5812/hepatmon.35278